(Journal of Neuroscience). A report of a serious adverse event in Sarepta Therapeutics' clinical trial of Duchenne muscular dystrophy gene therapy …


Link to Full Article: Read Here

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!